| Filed | Form | Description | |
|---|---|---|---|
| 7/14/25 | DEFA14A | DEFA14A | → |
| 7/10/25 | DEFA14A | DEFA14A | → |
| 6/6/25 | DEFA14A | DEFA14A | → |
| 6/6/25 | DEF 14A | DEF 14A | → |
| 5/23/25 | PRE 14A | PRE 14A | → |
| 7/22/24 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/9/26 | 4 | PRIMARY DOCUMENT | → |
| 3/9/26 | 4 | PRIMARY DOCUMENT | → |
| 3/9/26 | 4 | PRIMARY DOCUMENT | → |
| 3/9/26 | 4 | PRIMARY DOCUMENT | → |
| 3/9/26 | 4 | PRIMARY DOCUMENT | → |
| 3/9/26 | 4 | PRIMARY DOCUMENT | → |
| ↓ | |||
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.